FDA Reports Fosamax May Not Help Women Long Term

Share Article

According to the FDA analysis published on May 9th, 2012 in the New England Journal of Medicine, bone-strengthening drugs such as Fosamax may have little long-term benefit. Fosamax, manufactured by Merck, is a drug developed to treat osteoporosis and other bone-related diseases. It was approved by the FDA in 1995. On February 27th, 2012, a jury trial began in the Superior Court for Atlantic County, New Jersey in In re: Fosamax Litigation (No. 282). Plaintiffs allege that using Fosamax caused them to develop osteonecrosis of the jaw (ONJ). ONJ is a rare bone disease that can cause the patient's jaw bone to deteriorate and die. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fosamax severe adverse events. http://www.attorneyone.com/fosamax-lawsuit/.

Fosamax severe adverse events threat

Fosamax severe adverse events threat

side effects of Fosamax may include Osteonecrosis of the Jaw (ONJ)

The media spotlight is often a double-edged sword. No one knows this better than people who suffer from Fosamax Side Effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked, according to Sean Burke of AttorneyOne.

According to the FDA analysis published on May 9th, 2012 in the New England Journal of Medicine, bone-strengthening drugs such as Fosamax may have little long-term benefit. Fosamax, manufactured by Merck and approved by the FDA in 1995, is a drug developed to treat osteoporosis and other bone-related diseases.

On February 27th, 2012, a jury trial began in the Superior Court for Atlantic County, New Jersey in In re: Fosamax Litigation (No. 282). Plaintiffs allege that using Fosamax caused them to develop osteonecrosis of the jaw (ONJ). ONJ is a rare bone disease that can cause the patient's jaw bone to deteriorate and die. To repair jaw bone damage, a painful surgery is required to remove dying bone tissue. Approximately 2,400 patients have reported ONJ since 2001.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Fosamax severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Fosamax remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In December 2007, the connection discovered between the class of drugs known as bisphosphonates, including Fosamax, and Osteonecrosis of the Jaw (ONJ) was published in the Journal of Oral and Maxillofacial Surgeons, revealing that the side effects of Fosamax may include ONJ. In January 2011, the FDA issued a warning noting that bisphosphonates (incl. Fosamax) have been linked to atypical femur fractures.

AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Fosamax at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/5/prweb9496214.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
1-877-230-7343
Email >
Follow us on
Visit website